Is Spina bifida hereditary?

Spina bifida is considered a multifactorial condition, meaning it results from a complex interaction between genetic predispositions and environmental factors, rather than following a single-gene inheritance pattern. While it is not strictly "hereditary" in the sense of simple Mendelian inheritance, families with a history of neural tube defects (NTDs) face a statistically higher risk of recurrence in future pregnancies.

Is Spina bifida hereditary?

Spina bifida is not caused by a single faulty gene; instead, it is a multifactorial condition. This means that both genetic susceptibility and external influences—most notably maternal folic acid levels during early pregnancy—contribute to the development of the condition. Because it is not a classic hereditary disorder, it does not follow predictable Mendelian patterns like autosomal dominant or recessive inheritance.

What is the recurrence risk for families?

If a parent or a previous child has been diagnosed with spina bifida, the risk of recurrence in subsequent pregnancies is generally estimated to be between 2% and 5%. This is significantly higher than the risk in the general population, which is roughly 1 in 1,000 births. Because spina bifida is multifactorial, the risk is cumulative; having multiple affected family members may slightly increase these percentages.

What role does genetic testing and counseling play?

Genetic testing is not typically used to "diagnose" spina bifida itself, as it is a structural birth defect identified through imaging. However, genetic counseling is highly recommended for families planning a pregnancy. Counselors help by:

• Reviewing family history to assess specific recurrence risks.


• Discussing the critical role of folic acid supplementation (often at higher doses for high-risk individuals) before and during early pregnancy.


• Providing information on prenatal screening options, such as maternal serum alpha-fetoprotein (MSAFP) testing and high-resolution fetal ultrasounds.


• Supporting families who have a child with spina bifida to navigate the complexities of long-term care for the nervous and skeletal systems.

Are de novo mutations common in Spina bifida?

De novo (spontaneous) mutations are not the primary driver of spina bifida. The condition is overwhelmingly linked to the interaction between polygenic risks and environmental triggers. While rare chromosomal abnormalities can sometimes present with similar structural features, the vast majority of spina bifida cases arise from the interplay of maternal nutrition, metabolic factors, and multifactorial genetic susceptibility.

Next steps

• Consult a genetic counselor if you have a family history of neural tube defects.


• Speak with your OB/GYN about recommended folic acid dosages for your specific health profile.


• Connect with the 207 members of the DiseaseMaps.org community who share lived experiences with spina bifida.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified healthcare provider with any questions regarding a medical condition.

References

• National Institute of Neurological Disorders and Stroke (NINDS) - Spina Bifida Fact Sheet


• NIH Genetic and Rare Diseases (GARD) Information Center


• Orphanet: Neural tube defects


• Spina Bifida Association (SBA)